Related Experiment Videos
Cardiac valvular disease and stroke
1Department of Medicine, Medical University of South Carolina, Charleston.
Neurologic Clinics
|May 1, 1993
Summary
Thromboembolic complications from heart valve issues, including native and prosthetic valves, cause significant cerebrovascular accidents. This article reviews the use of anticoagulation therapy for these conditions.
Area of Science:
- Cardiology
- Neurology
- Hematology
Background:
- Cerebrovascular accidents (CVAs) are a major health concern, often stemming from thromboembolic events.
- Complications arise from both native heart valve disease and prosthetic valves, necessitating careful management.
Purpose of the Study:
- To discuss the critical role of anticoagulation in managing thromboembolic complications associated with heart valve abnormalities.
- To provide an overview of current understanding and therapeutic strategies.
Main Methods:
- Literature review of studies on thromboembolism and valve disease.
- Analysis of anticoagulation's efficacy and risks in different patient populations.
- Discussion of clinical guidelines and expert opinions.
Main Results:
- Anticoagulation is a cornerstone in preventing CVAs secondary to thromboembolism in native and prosthetic valve disease.
- The choice and management of anticoagulation require careful consideration of individual patient factors, valve type, and risk of bleeding versus thrombosis.
Conclusions:
- Effective anticoagulation strategies are essential for reducing the incidence of cerebrovascular accidents in patients with heart valve disease.
- Further research may refine optimal anticoagulation protocols for diverse clinical scenarios.